NCT02392247View on ClinicalTrials.gov

Hemosonics- VCU Cardiac Surgery Clinical Study

CompletedOBSERVATIONAL

Enrollment

52

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions

Cardiopulmonary Bypass

Interventions

DEVICE

Coagulation function

Coagulation function assessment tools TEG (standard of practice) vs SEER Quantra (novel coagulation function device)

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

HemoSonics LLC

INDUSTRY

lead

Virginia Commonwealth University

OTHER

NCT02392247 - Hemosonics- VCU Cardiac Surgery Clinical Study | Biotech Hunter | Biotech Hunter